SHORT COMMUNICATION
Children hospitalized for juvenile arthritis in the United States
More details
Hide details
1
Department of Medicine, Liaquat University of Medical and Health Sciences Hospital, Karachi, Pakistan
2
Department of Pediatrics, Shanghai Xin Hua Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China
3
Department of Medicine, Sir Seewoosagur Ramgoolam National Hospital, Pamplemousses, Mauritius
4
Department of Internal Medicine, Guru Gobind Singh Medical College, Punjab, India
5
Department of Pediatrics, The University Iberoamericana Unibe School of Medicine/Robert Reid Cabral Children’s Hospital, Santo Domingo, Dominicana
6
Department of Pediatrics, the Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
Submission date: 2021-03-22
Final revision date: 2021-07-05
Acceptance date: 2021-07-27
Online publication date: 2021-08-16
Publication date: 2021-09-02
Reumatologia 2021;59(4):270-272
KEYWORDS
TOPICS
ABSTRACT
Juvenile arthritis (JA) is an autoimmune condition affecting children. We used the 2017 National Inpatient Sample (NIS) to evaluate the impact of JA in the United States. The admission data were converted to weighted form and patients between the ages of 0 and 18 (inclusive) were used in our study. 560 weighted cases were found in 2017. It was more common in females than males (340 females, 220 males), Whites (235 cases), and Medicaid covered 61.6% of all patients with JA (345 cases). The total hospital charges were $25,147,389 while the mean length of stay (LOS) was 4.55 days. The highest number of cases was reported in April 2017.
REFERENCES (18)
1.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH). Juvenile arthritis [cited 2021 22nd March]; Available from:
https://www.niams.nih.gov/heal....
2.
Healthcare Cost and Utilization Project (HCUP). HCUP National Inpatient Sample (NIS). 2017. Agency for Healthcare Research and Quality, Rockville, MD [cited 2020 July 1st]; Available from:
https://www.hcup-us.ahrq.gov/n....
4.
Berthold E, Månsson B, Kahn R. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. Arthritis Res Ther 2019; 21: 218, DOI: 10.1186/s13075-019-1994-8.
5.
Ehrmann Feldman D, Bernatsky S, Houde M. The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study. Pediatr Rheumatol Online J 2009; 7: 20, DOI: 10.1186/1546-0096-7-20.
6.
Abujam B, Mishra R, Aggarwal A. Prevalence of musculoskeletal complaints and juvenile idiopathic arthritis in children from a developing country: a school-based study. Int J Rheum Dis 2014; 17: 256–260, DOI: 10.1111/1756-185X.12276.
7.
Danner S, Sordet C, Terzic J, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 2006; 33: 1377–1381.
8.
Yu HH, Chen PC, Wang LC, et al. Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan. PLoS One 2013; 8: e70625, DOI: 10.1371/journal.pone.0070625.
9.
Ng PC, Ooi PL, Ang E, et al. SAT0476 juvenile idiopathic arthritis in Singapore: a 10-year clinical experience. Ann Rheum Dis 2019; 78 (Suppl 2): 1326–1326, DOI: 10.1136/annrheumdis-2019-eular.3593.
10.
Modesto C, Antón J, Rodriguez B, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol 2010; 39: 472–479, DOI: 10.3109/03009741003742722.
11.
Macaubas C, Nguyen K, Milojevic D, et al. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 2009; 5: 616–626, DOI: 10.1038/nrrheum.2009.209.
12.
Harrold LR, Salman C, Shoor S, et al. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996–2009. J Rheumatol 2013; 40: 1218–1225, DOI: 10.3899/jrheum.120661.
13.
Krause ML, Crowson CS, Michet CJ, et al. Juvenile idiopathic arthritis in Olmsted County, Minnesota, 1960–2013. Arthritis Rheumatol 2016; 68: 247–254, DOI: 10.1002/art.39323.
14.
Beukelman T, Anink J, Berntson L, et al. A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities. Pediatr Rheumatol Online J 2017; 15: 31, DOI: 10.1186/s12969-017-0161-5.
15.
Cattalini M, Soliani M, Caparello MC, Cimaz R. Sex differences in pediatric rheumatology. Clin Rev Allergy Immunol 2019; 56: 293–307, DOI: 10.1007/s12016-017-8642-3.
16.
Ringold S, Beukelman T, Nigrovic PA, et al. Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013; 40: 936–942, DOI: 10.3899/jrheum.121147.
17.
Pelajo CF, Angeles-Han ST, Prahalad S, et al. Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis. Rheumatol Int 2013; 33: 2549–2554, DOI: 10.1007/s00296-013-2773-5.
18.
Feldman BM, Birdi N, Boone JE, et al. Seasonal onset of systemic-onset juvenile rheumatoid arthritis. J Pediatr 1996; 129: 513–518, DOI: 10.1016/s0022-3476(96)70115-4.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.